Strides Pharma gains after arm receives US-FDA nod for Pregabalin capsule
The Pregabalin capsule is used in the treatment of fibromyalgia, is a chronic health condition that causes pain and tenderness throughout the body. Strides Pharma Science share price gained a percent in the opening trade on January 29 after the company said it received the approval of the United States Food and Drug Administration (USFDA) approval to sell a generic drug for nerve pain.
The company's step‐down wholly owned subsidiary Strides Pharma Global Pte Limited, Singapore has received the nod for Pregabalin capsules, 25 mg, 50mg, 75mg, 100mg, 150mg, 200mg, 225mg, 300mg from the US drug regulator.
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD), Lyrica capsules of Upjohn US. The capsule is used in the treatment of fibromyalgia.
Let’s apply Data-Driven Pricing to Your APIs
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions!
Learn More!